Roche Receives FDA Clearance for New Respiratory Pathogen Panel
The FDA cleared Roche's new cobas eplex Respiratory Pathogen Panel 3 through the 510(k) pathway.
Related stories
Judge Dismisses Case Against Former FBI Officials
A judge dismissed the case against former FBI officials and said the Justice Department rushed the charges before the midterms.
L impact | REGULATION | Nov 02, 2026, 05:38 PM UTC
China launches measures to support struggling capital markets
M impact | REGULATION | Nov 02, 2026, 05:26 PM UTC
USTR Removes Rwanda, South Africa From AGOA Trade Preference Process
The U.S. Trade Representative cited trade barriers and national security threats in removing Rwanda and South Africa from the U.S. African Growth and Opportunity Act trade preferen
M impact | REGULATION | Nov 02, 2026, 05:16 PM UTC
ECB Cuts Novo Banco’s 2027 Pillar 2 Capital Requirement to 2.35%
The ECB lowered Novo Banco’s 2027 Pillar 2 capital requirement by 15 basis points, to 2.35%.
M impact | REGULATION | Nov 02, 2026, 05:10 PM UTC
Trump Administration Takes California Ballot Fight to Supreme Court
The Trump administration has taken a California ballot dispute to the Supreme Court.
L impact | REGULATION | Nov 02, 2026, 05:06 PM UTC
US to Suspend South Africa and Rwanda From Duty-Free Trade Access
M impact | REGULATION | Nov 02, 2026, 05:05 PM UTC